Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims (Q44765964)

6 December 2017

Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims (English)

1 reference

6 December 2017

Balapal S Basavarajappa

4

1 reference

6 December 2017

8

1 reference

6 December 2017

Hungund BL

1

1 reference

6 December 2017

Vinod KY

2

1 reference

6 December 2017

Kassir SA

3

1 reference

6 December 2017

Yalamanchili R

5

1 reference

6 December 2017

Cooper TB

6

1 reference

6 December 2017

Mann JJ

7

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

6 December 2017

1 reference

6 December 2017

9

1 reference

6 December 2017

184-190

1 reference

6 December 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001376

6 December 2017

0 references

cites work

Neurobiology of marijuana abuse.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

The endocannabinoid system as a target for therapeutic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Cannabinoids and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Serotonin brain circuits involved in major depression and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: selective supersensitivity of alpha(2A)-adrenoceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Ethanol, endocannabinoids, and the cannabinoidergic signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Validity of DSM-III-R diagnosis by psychological autopsy: a comparison with clinician ante-mortem diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

G proteins: transducers of receptor-generated signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Relationships between ligand affinities for the cerebellar cannabinoid receptor CB1 and the induction of GDP/GTP exchange.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

The neurobiology of suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Health aspects of cannabis: revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Cannabis and psychotic illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

A comment on the "amotivational syndrome" in marijuana smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Endocannabinoid signaling in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

Characterization of receptor-mediated [35S]GTPgammaS binding to cortical membranes from postmortem human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

7 January 2021

Elevated endogenous cannabinoids in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

7 January 2021

Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

7 January 2021

Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001376

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001376

1 reference

Dimensions Publication ID

6 December 2017

0 references

1 reference